Embed Size (px)
Citation preview
CommentComment
www.thelancet.com www.thelancet.com Vol 377 February 12, 2011
Stemming the global tsunami of cardiovascular Stemming the global tsunami of cardiovascular diseasedisease
An epidemic of risk factors for cardiovascular disease
The Lancet, Volume 377, Issue 9765, Page 527, 12 February 2011
INFLAMACION Y ENFERMEDAD CARDIOVASCULAR
CRP: star trekking the galaxy of risk markers
Editorial
C reactive protein and the risk of cardiovascular disease
C reactive protein and the risk of cardiovascular disease
Are clearly linked but a causal association is unlikely
Editorial
Figure 2
MICROBIOMA HUMANO
Y ENFERMEDAD CARDIOVASCULAR
LDL Y ENFERMEDAD CARDIOVASCULAR:
MÁS ALLÁ DE LAS ESTATINAS
HDL Y ENFERMEDAD CARDIOVASCULAR
HDL and Cardiovascular-Disease Risk — Time for a New Approach?
N Engl J Med 2011; 364:170-171 January 13, 2011
Editorial
Jay Heinecke, M.D.
Clinical Implications of Basic Research
Sorting Out Cholesterol and Coronary Artery Disease
Patrick Linsel-Nitschke, M.D., Nilesh J. Samani, M.D., M.B., Ch.B., and Heribert Schunkert, M.D.
N Engl J Med 2010; 363:2462-2463
Sortilin 1 and the Risk of Coronary Disease.
Linsel-Nitschke P et al. N Engl J Med 2010;363:2462-2463.
EPIGENÉTICA Y ENFERMEDAD CARDIOVASCULAR
INSULINORESISTENCIA Y ENFERMEDAD CARDIOVASCULAR
A Comparison of PPARγ Activity in Lean and Obese Persons.
Kahn BB, McGraw TE. N Engl J Med 2010;363:2667-2669.
NUTRICIÓN Y ENFERMEDAD CARDIOVASCULAR
Volume 362:2102-2112 June 3, 2010 Number 22
REPROGRAMACIÓN CELULAR Y ENFERMEDAD CARDIOVASCULAR
Clinical Implications of Basic Research
Reprogramming Fibroblasts into Cardiomyocytes
Charles E. Murry, M.D., Ph.D., and William T. Pu, M.D.
N Engl J Med 2011; 364:177-17
The Path from Fibroblast to Cardiomyocyte.
Murry CE, Pu WT. N Engl J Med 2011;364:177-178.
LA POBREZA Y ENFERMEDAD CARDIOVASCULAR
